1H and31P magnetic resonance spectroscopic imaging of white matter signal hyperintensity areas in elderly subjects

Neuroradiology

Volumn 37, Issue 8, 1995, Pages 615-623

  Constans, J M ^a,b   Meyerhoff, D J ^a,b   Norman, D ^b   Fem, G ^b   Weiner, M W ^a,b,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ischemia; Magnetic resonance imaging; Magnetic resonance spectroscopic imaging; N Acetylaspartate; Normal aging; White matter signal changes

Indexed keywords

ASPARTIC ACID; CHOLINE; DRUG DERIVATIVE; MYELIN PROTEIN; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE; PHOSPHATE; PHOSPHOLIPID; MYELIN;

AGED; ARTICLE; BRAIN; CHRONIC BRAIN DISEASE; ENERGY METABOLISM; FEMALE; HUMAN; IMAGE PROCESSING; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MYELINATED NERVE; NERVE FIBER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; ADULT; ALZHEIMER DISEASE; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

AGED; AGED, 80 AND OVER; ASPARTIC ACID; AXONS; BRAIN; BRAIN DAMAGE, CHRONIC; CHOLINE; ENERGY METABOLISM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYELIN PROTEINS; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; PHOSPHATES; PHOSPHOLIPIDS; REFERENCE VALUES;

EID: 0028973546     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/BF00593373     Document Type: Article

References (55)

1. MR signal abnormalities in memory disorder and dementia
2. Patchy, periventricular white matter lesions in the elderly: a common observation during NMR imaging
3. Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly
4. Magnetic resonance imaging of the aging brain: patchy white matter lesions in dementia
5. Imaging of the aging brain, part I. Normal findings
6. Risk factors for white matter changes detected by magnetic resonance imaging in the elderly
7. Physiological responses of local areas of the cerebral circulation in experimental primates determined by the method of hydrogen clearance
8. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations
9. The morphologic correlate of incidental punctate white matter hyperintensities on MR images
10. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter
11. Neuropathologic correlates of leuko-araiosis
12. White-matter lesions in MR imaging of clinically healthy brain of elderly subjects: possible pathology basis
13. Deep white matter infaction: correlation of MR imaging and histopathologic findings
14. Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging
15. Foci of MRI signal (pseudolesions) anterior to the frontal horns: histologic correlations of a normal findings
16. White matter disorder in dementia of the alzheimer type: a pathoanatomical study
17. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia
18. White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia: diagnostic and pathogenetic aspects
19. White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study
20. Magnetic resonance findings in patients with early-onset Alzheimer's disease
21. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity
22. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging
23. Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. Multicenter AIDS cohort study
24. White matter disease in AIDS: findings at MR imaging
25. White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly
26. Clinical significance of MRI white matter lesions in the elderly
27. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging
28. N-Acetyl-1-aspartic acid content of human neural tumours and bovine peripheral nervous tissues
29. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in-vitro
30. N-Acetyl- L-aspartatic acid: a literature review of a compound prominent in1H-NMR spectroscopic studies of the brain
31. Studies on the distribution of N-acetyl- L-aspartic acid in brain
32. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities
33. Alterations in brain phosphorus metabolite concentrations associated with areas of high signal intensity in white matter at MR imaging
34. Spatially resolved high resolution spectroscopy by “four dimensional” NMR
35. NMR chemical shift imaging in three dimensions
36. Spin echo31P spectroscopic imaging in the human brain
37. Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains
38. 3D phase encoding1H spectroscopic imaging of human brain
39. Mini-mental state
40. The Neurobehavorial Cognitive Status Examination: a brief but differential approach to cognitive assessment
41. Spectroscopic imaging display and analysis
42. A review of chemical issues in1H NMR spectroscopy: N-acetyl- L-aspartate, creatine and choline
43. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease
44. Evidence for membrane defect in Alzheimer's disease brain
45. Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain
46. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy
47. Elevated lactate and alkalosis in chronic human brain infarction observed by1H and31P MR spectroscopic imaging
48. Could Wallerian degeneration contribute to “leukoaraiosis” in subjects free of any vascular disorder?
49. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo31P and1H spectroscopic imaging
50. Human brain infarction: proton MR spectroscopy
51. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo1H magnetic resonance spectroscopic imaging
52. White matter hyperintensities may correspond to areas of increased blood volume: correlative MR and PET observations
53. Computer simulation of MRS localization techniques: an analysis of ISIS